An interventional study of Stepped care and Usual Care in COPD (Chronic Obstructive Pulmonary Disease), sponsored by Copenhagen University Hospital, Hvidovre. Recruiting at 1 site in Denmark. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-12-10.
Sponsored by Copenhagen University Hospital, Hvidovre · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 242 studies in Pulmonary Disease, Chronic Obstructive with a site in Denmark — 34 open to participants now, 42 under way, 8 of them phase 3. Pulmonary Disease, Chronic Obstructive · Denmark.
Among the 242 studies in Pulmonary Disease, Chronic Obstructive with a site in Denmark, this one is the 137th largest by planned enrollment of the 209 interventional ones that give a count, is one of 13 that started in 2025, is one of 84 with no phase, reaches primary completion later than 13 of the 41 other live ones, and was the 226th registered.
5,522 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 857 are open to participants now.
Browse Pulmonary Disease, Chronic Obstructive studies →34 of the 242 studies in Pulmonary Disease, Chronic Obstructive with a site in Denmark are open now. Recruiting first, the newest first:
Chronic Obstructive Pulmonary Disease Trial Network, Denmark · Sites in Denmark
Ages 18+
Eli Lilly and Company · Sites in Denmark, United States, Argentina and 15 more countries
Ages 40–75
Vejle Hospital · Sites in Denmark
Ages 50+
Steno Diabetes Center Copenhagen · Sites in Denmark
Ages 18+
Vejle Hospital · Sites in Denmark
Ages 50+
A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →
Of the 557 Pulmonary Disease, Chronic Obstructive studies recruiting now, 306 (55%) set no upper age limit and 82 (15%) stop at 75 or younger; 29 take children under 18; 89 take healthy volunteers.
This study: 65 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
242 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 27 · Phase 3 61 · Phase 4 35
First in 1999; this study’s year is marked. 13 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is above the median of 62 across 3,840 interventional studies indexed under Pulmonary Disease, Chronic Obstructive.
Median enrollment 182 across the 209 interventional studies, 194 across the 33 observational. Of the 171 that completed or were terminated, 74 (43%) have results posted.
This tab as a report to print or save as PDF → With an account.
111 of 242 have an industry lead sponsor. The 10 most frequent:
Copenhagen University Hospital, Hvidovre is the lead sponsor of 79 studies on the registry; 19 are open to participants now.
Copenhagen University Hospital, Hvidovre has 5 studies filed under Pulmonary Disease, Chronic Obstructive — fewer than ten, so there is no comparison to draw.
16 of the studies in Pulmonary Disease, Chronic Obstructive with a site in Denmark that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05878769Phase 3Hoffmann-La RocheA Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) | 2027-06-30 |
| NCT07555483Phase 3Grifols Therapeutics LLCA Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD) | 2027-09-30 |
| NCT06163131Aarhus University HospitalThe Effect of Treatment of Emphysema With Endobronchial Valves on the Diaphragm Mobility | 2026-11-27 |
| NCT06677593Copenhagen University Hospital, HvidovreDetection of Electrodermal Activity in Pain 2 | 2026-12-01 |
| NCT07428785Copenhagen University Hospital, RigshospitaletPulmonary and Total Blood Volume in COPD | 2026-12-20 |
Add all 16 to your calendar (.ics) → With an account.
Among the 242 studies in Pulmonary Disease, Chronic Obstructive with a site in Denmark, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The aim of this study is to explore the feasibility and potential for a positive impact of a graduated response for advanced COPD with Enhanced Support. The study is a randomized controlled trial of:
The current study is a non-blinded randomized controlled pilot trial. The control group will be offered treatment as usual whereas the intervention group will be allocated to the GRACE model of care. In total, 100 patients and their caregivers will be included. The patients are all community dwelling and attached to the Outpatient Respiratory Medicine Clinic at Hvidovre Hospital. The patients will be randomized by block randomization to intervention and control group with a ratio of 1:1. Furthermore, the patients will be stratified according to which municipality they belong to, to ensure we gather feasibility data from two municipalities. The control group will be offered to be assessed for their eligibility for palliative care through the existing visitation conference at the end of the trial period. Endpoints include: Patient-reported (quality of life, anxiety and depression, self-efficacy), caregiver-reported ( caregiver burden, anxiety and depression, well-being) and patient healthcare use.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
ICECAP-SCM at least two scores of:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cross-sectoral stepped care with systematic needs assessment, advance care planning and virtual conferences
Other: Stepped care · Other: Usual Care
Care as usual at the outpatient respiratory clinic
Other: Usual Care
Graduated palliative cross-sectoral care
Usual care at the outpatient respiratory clinic
ICECAP-SCM
Time frame: 6 months
ICECAP-SCM
Time frame: 3 months
ICECAP-SCM
Time frame: 9 months
ICECAP-SCM
Time frame: 12 months
HADS
Anxiety and depression
Time frame: 3
HADS
Anxiety and depression
Time frame: 6
HADS
Anxiety and depression
Time frame: 9 months
HADS
Anxiety and depression
Time frame: 12 months
GSE
General self-efficacy scale
Time frame: 3 months
GSE
General self-efficacy scale
Time frame: 6 months
GSE
General self-efficacy scale
Time frame: 9 months
GSE
General self-efficacy scale
Time frame: 12 months
Hospital admissions
* Proportion of patients with any hospital admission * Mean number of admissions per patient * Bed days
Time frame: 3 months
Hospital admissions
* Proportion of patients with any hospital admission * Mean number of admissions per patient * Bed days
Time frame: 6 months
Hospital admissions
* Proportion of patients with any hospital admission * Mean number of admissions per patient * Bed days
Time frame: 9 months
Hospital admissions
* Proportion of patients with any hospital admission * Mean number of admissions per patient * Bed days
Time frame: 12 months
Healthcare use, municipality
Time frame: 3 months
Healthcare use, municipality
Time frame: 6 months
Healthcare use, municipality
Time frame: 9 months
Healthcare use, municipality
Time frame: 12 months
Healthcare use, hospital
Time frame: 3 months
Healthcare use, hospital
Time frame: 6 months
Healthcare use, hospital
Time frame: 9 months
Healthcare use, hospital
Time frame: 12 months
Healthcare use, general practice
Time frame: 3 months
Healthcare use, general practice
Time frame: 6 months
Healthcare use, general practice
Time frame: 9 months
Healthcare use, general practice
Time frame: 12 months
Survival
Time frame: 12 months
SF12
Health-related quality of life
Time frame: 3 months
SF12
Health-related quality of life
Time frame: 6 months
SF12
Health-related quality of life
Time frame: 9 months
SF12
Health-related quality of life
Time frame: 12 months
Plan to share: Undecided
No publications or documents are linked to this record.
Started Aug 2025 (actual). Primary completion is estimated for Dec 2026, 16 months after the start.
Of 1,095 non-industry interventional studies with no phase under Pulmonary Disease, Chronic Obstructive, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 16 months is below that.
Counting every sponsor, half of 1,182 studies reached it within 22 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pulmonary Disease, Chronic Obstructive →
Copenhagen University Hospital, Hvidovre